Actively Recruiting
Observational Study to Describe Health-Related Quality of Life and Measure Disease Burden Among Patients With Long QT Syndrome Types (LQTS) 2 and 3
Led by Thryv Therapeutics, Inc. · Updated on 2025-11-17
200
Participants Needed
1
Research Sites
57 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a cross-sectional observational study designed to assess the disease burden and quality of life in individuals with LQTS 2 and 3. Each participant will answer each patient-reported outcome questionnaire only once over a 6-month period. The study will enroll up to 200 participants.
CONDITIONS
Official Title
Observational Study to Describe Health-Related Quality of Life and Measure Disease Burden Among Patients With Long QT Syndrome Types (LQTS) 2 and 3
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants must be 18 years or older and speak English.
- Willing to provide written informed consent.
- Confirmed genetic diagnosis of LQTS type 2 or 3 by genetic testing or physician's letter.
- Documented QTc value of 480 ms or higher within the past year by ECG or physician's letter.
- Able to operate a smartphone and companion watch (Apple iPhone and Apple Watch).
- Limited to 50 participants with QTc between 480 and 500 ms.
You will not qualify if you...
- Currently participating in another clinical trial involving a drug or device.
- Unwilling to use an iPhone or Apple Watch for the study duration.
- Known diagnosis of Brugada Syndrome.
- Unwilling to comply with study procedures.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
East Carolina University
Greenville, North Carolina, United States, 27858
Actively Recruiting
Research Team
S
Study Coordinator
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here